ENTBF.US Entheon Biomedical Corp

Healthcare Biotechnology USA Stocks
0.0600 USD
Close of Nov 14, 2026
0.0040 0.1040
Market cap
USD 832K
P/E
6.0x
P/B
2.45x
ROE
-100.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Mar 2026.

Is ENTBF.US undervalued?

Graham number
Price0.0600
Graham value0.0742
Discount19.1%

ENTBF.US trades 19.1% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Entheon Biomedical Corp fundamental analysis

No fundamental analysis for Entheon Biomedical Corp yet.

Entheon Biomedical Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Entheon Biomedical Corp

Entheon Biomedical Corp. operates as a biotechnology research and development company. It develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.

Full company profile